SCHEMBL25906163

SCHEMBL25906163

CC(C)(C)c1ccc(Br)c(Oc2ccccc2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RIPK1 Q13546 1/20 0.41
▸ MAPT P10636 3/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ HPGD P15428 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ LTA4H P09960 2/20 0.37
▸ TSHR P16473 1/20 0.37
▸ CA1 P00915 1/20 0.37
▸ CA2 P00918 1/20 0.37
▸ CA9 Q16790 1/20 0.37
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ PLA2G1B P04054 1/20 0.36
▸ NFKB1 P19838 1/20 0.36
▸ CASP3 P42574 1/20 0.36
▸ NFKB2 Q00653 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22169891 0.81 RIPK1 (0.42) RIPK1MAPTNPC1ALDH1A1RAB9A
SCHEMBL10708734 0.79 ALDH1A1 (0.50) RIPK1MAPTNPC1ALDH1A1RAB9A
SCHEMBL15472490 0.79 TTR (0.55) RIPK1MAPTALDH1A1MAPK1LTA4H
SCHEMBL22888750 0.79 ALDH1A1 (0.50) RIPK1MAPTALDH1A1RAB9AMAPK1
SCHEMBL22889045 0.79 RIPK1 (0.41) RIPK1MAPTNPC1ALDH1A1RAB9A
SCHEMBL22751142 0.79 RIPK1 (0.41) RIPK1MAPTNPC1ALDH1A1RAB9A
SCHEMBL12261813 0.79 KDM4E (0.46) RIPK1MAPTNPC1ALDH1A1RAB9A
SCHEMBL25586333 0.77 MAPT (0.43) RIPK1MAPTNPC1ALDH1A1RAB9A
SCHEMBL11047623 0.77 MAPT (0.44) MAPTNPC1ALDH1A1RAB9AHPGD
SCHEMBL14471080 0.76 RIPK1 (0.41) RIPK1MAPTNPC1ALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11713335-B2 Aminocoumarin compounds and methods of their use PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2023-08-01 — — US disclosed
US-11713335-B2 Aminocoumarin compounds and methods of their use PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2023-08-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11713335-B2 Aminocoumarin compounds and methods of their use AAAS, PROC, AADAC RIPK1 4759/4885MAPT 4494/4885NPC1 2550/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback